Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Sokoloff

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of Urology|June 17, 1998
Innovative therapies for human prostate cancerM H Sokoloff
International Journal of Urology : Official Journal of the Japanese Urological Association|December 6, 2013
Immunotherapy and gene therapy for genitourinary malignanciesM H Sokoloff, A Belldegrun
Cancer|December 14, 1999
The ongoing evolution of dendritic cell therapyM H Sokoloff, N Vogelzang
The Urologic Clinics of North America|October 10, 2001
Indications and contraindications for nerve-sparing radical prostatectomyM H Sokoloff, C B Brendler
Cancer Metastasis Reviews|August 24, 1999
Targeting angiogenic pathways involving tumor-stromal interaction to treat advanced human prostate cancerM H Sokoloff, L W Chung
CA: a Cancer Journal for Clinicians|September 1, 1996
Current management of renal cell carcinomaM H Sokoloff, J B deKernion, R A Figlin, et al.
BJU International|March 11, 2004
Characterizing prostatic adenocarcinomas in men with a serum prostate specific antigen level of < 4.0 ng/mLM H Sokoloff, X J Yang, M Fumo, et al.
BJU International|June 8, 2004
Relationship of erythrocyte membrane polyunsaturated fatty acids and prostate-specific antigen levels in Jamaican menC R Ritch, C B Brendler, R L Wan, et al.
Cancer|August 5, 2000
Surgical and postoperative factors affecting length of hospital stay after radical prostatectomyT A Gardner, E A Bissonette, G R Petroni, et al.
Circulation|November 1, 1990
The reversibility of canine vein-graft arterializationJ I Fann, M H Sokoloff, G E Sarris, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Urology|June 17, 1998
Innovative therapies for human prostate cancerM H Sokoloff
International Journal of Urology : Official Journal of the Japanese Urological Association|December 6, 2013
Immunotherapy and gene therapy for genitourinary malignanciesM H Sokoloff, A Belldegrun
Cancer|December 14, 1999
The ongoing evolution of dendritic cell therapyM H Sokoloff, N Vogelzang
The Urologic Clinics of North America|October 10, 2001
Indications and contraindications for nerve-sparing radical prostatectomyM H Sokoloff, C B Brendler
Cancer Metastasis Reviews|August 24, 1999
Targeting angiogenic pathways involving tumor-stromal interaction to treat advanced human prostate cancerM H Sokoloff, L W Chung
CA: a Cancer Journal for Clinicians|September 1, 1996
Current management of renal cell carcinomaM H Sokoloff, J B deKernion, R A Figlin, et al.
BJU International|March 11, 2004
Characterizing prostatic adenocarcinomas in men with a serum prostate specific antigen level of < 4.0 ng/mLM H Sokoloff, X J Yang, M Fumo, et al.
BJU International|June 8, 2004
Relationship of erythrocyte membrane polyunsaturated fatty acids and prostate-specific antigen levels in Jamaican menC R Ritch, C B Brendler, R L Wan, et al.
Cancer|August 5, 2000
Surgical and postoperative factors affecting length of hospital stay after radical prostatectomyT A Gardner, E A Bissonette, G R Petroni, et al.
Circulation|November 1, 1990
The reversibility of canine vein-graft arterializationJ I Fann, M H Sokoloff, G E Sarris, et al.
Pageof 2